In a prior post I lightly dissed Circadian’s new name (ASX : CIR) – Opthea. In my defence, you surely knew it was coming… though I should clarify, for the avoidance of doubt, that I have always liked the name Opthea better than “sister company” Vegenics. Yuk. The word “vegenics” can only ever be credibly used in the following sentence construction – “last month I picked up a nasty case of the vegenics on vacation in Bangkok, but a dose of antibiotics sorted it out.”
… but I digress…
One reader of Scottish origin told me that my exploitative and unflattering use of a photograph of an old woman drinking scotch-on-the-rocks was in poor taste. I concur that scotch should never be consumed in large quantities with ice, and I apologise unreservedly on behalf of the drinker. Another reader of Scandinavian origin told me that his gran’s name was Dorthea, and that if I didn’t like Opthea, I probably also wouldn’t like Dorthea. I think he was Danish, and I couldn’t tell if he was making a joke or being serious. Danes are challenging like that.
But, I have to admit that this is probably true. I don’t like Dorthea much more than Opthea. Maybe even less.
The best, however, was one reader’s interpretation that “Opthea” is surely some kind of feminine derivation of “Opthamology”, and that it was nice to see some feminine product branding in healthcare given that it is such a male-dominated environment and there are so many blokes obviously messing up the ASX bioscience space. I tried to argue that we already had Anisina, which is surely a feminine derivation of “anus”, but I don’t think my point was fully understood. I sort of tend to generally agree with this sentiment (i.e. need more women leading ASX bioscience companies).
I should note that if we are going to hypothesise about the etymology of Opthea, the ‘ea‘ arguably has its origins in the Anglicisation of the (female) Latin word illa – meaning ‘water’. This, combined with the Greek etymology of ophthalmos – or “eye” – means that Opthea practically means ‘eye-water’ or tears. For the sake of shareholders, I hope that my amateur-hour linguistic analysis doesn’t hold true.
Anyhow, apparently I caused some opthea – some tears.
I am sorry.
PS: For the all the comically-challenged individuals who read my posts and can’t tell when I am trying to be funny, I do actually like this company. Just not the name.